EMD Serono, the US-based biopharma business of Germany’s Merck KGaA, has promoted Craig Millian to senior vice president of neurology and immunology.
Millian most recently served as senior vice president and head of US fertility and endocrinology at EMD Serono, having first joined in 2010.
Previously, he was vice president, commercial at Vertex and has held commercial leadership roles at Pfizer and Sanofi.
Gary Zieziula, president and managing director of EMD Serono, said: “Craig is a dynamic leader with a proven track record of success.
“He has been instrumental in expanding our leadership in fertility and endocrinology, and he will bring that passion and expertise to the neurology and immunology business, furthering our commitment to improve care for people living with multiple sclerosis and other conditions as we advance our pipeline.”